BackLandos Biopharma Overview

Landos Biopharma Other Liabilities

Landos Biopharma's other liabilities is $0.

Get informed when a big investor buys or sells

+ Follow
Other Liabilities
$0.00
↓ 100.00% YoYΔ $2.30M vs prior year quarter

Peer average

Loading

Landos Biopharma Other Liabilities History

Loading

Landos Biopharma vs. peers: Other Liabilities Comparison

Loading

Landos Biopharma Other Liabilities Growth (YoY per quarter)

Latest change versus the prior comparable period (same company).

Loading

Balance Sheet Breakdown

Current CashShort Term InvestmentsReceivablesInventoryOther Current AssetsCurrent AssetsLong Term InvestmentsProperty Plant EquipmentGoodwillIntangible AssetsOther AssetsTotal AssetsNet Tangible AssetsAccounts PayableOther Current LiabilitiesTotal Current LiabilitiesLong Term DebtOther LiabilitiesMinority InterestTotal Liabilities

Landos Biopharma (LABP) FAQ

As of the most recent data (March 2024), LABP shows a other liabilities of $0. That compares with $-2.3M in the prior-year period — up 100.0% year over year. Scroll down for historical charts and peer comparison views.

Compared with the year-ago period, LABP's other liabilities is now $0 (was $-2.3M) — a 100.0% year-over-year increase. Pairing that YoY change with peer averages gives a clearer picture of whether Landos Biopharma is outperforming or lagging.

Tracking LABP's other liabilities over time shows whether Landos Biopharma is scaling, shrinking, or reshaping that part of the business. The current reading is $0 That compares with $-2.3M in the prior-year period — up 100.0% year over year. Multi-quarter patterns matter more than any single print, which is why this page emphasizes history and peer comparison charts.

Besides this other liabilities page, Stockcircle has Landos Biopharma's full stock overview, other financial metrics, insider and congress trade tabs, and tools to follow the stock. Together they help you connect other liabilities (currently $0) with ownership activity and broader fundamentals.

Landos Biopharma's other liabilities is $0; compare it with other Healthcare names on the peer chart. Typical ranges vary by sub-industry, so always sanity-check against the closest competitors, not just the whole sector bucket.